Archive for Medication updates

From 1 April the reimbursement price of Inclisiran will increase to £60.00. In addition, the DHSC has classified that all drugs from Part VIIIC – Arrangements of Payment for Products...

 Update Dispex members can login here to see the updates all together in one place, and in alphabetical order. Looking to join Dispex, please click here.

Name of SSP \ ref no. Start and end date Supporting guidance SSP081 Estradot® 100 microgram patches (PDF:215KB) 19 December 2024 to 04 April 2025 This SSP was amended on 14...

Final Update Dispex members can login here to see the updates all together in one place, and in alphabetical order. Looking to join Dispex, please click here.

Third Update Dispex members can login here to see the updates all together in one place, and in alphabetical order. Looking to join Dispex, please click here.

Source: NHSBSA Email- Hints and Tips Issue 58 3.2.25 We have released a new Antimicrobial Stewardship – Urinary Tract Infection (UTI) dashboard on ePACT2. The dashboard provides data on the prescribing of selected...

Dispex members can login here to see the updates all together in one place, and in alphabetical order.   Looking to join Dispex, please click here.

Drug Supply Page Dispex provides primary care focused updates on drug supply issues. Data is taken from the SPS website on a weekly basis. Dispex members can login here to see the updated...

Dispex members can login here to see the updates all together in one place, and in alphabetical order.   Looking to join Dispex, please click here.

Dispex members can login here to see the updates all together in one place, and in alphabetical order.   Looking to join Dispex, please click here.

Reclassification of Nexplanon as “Attracts an Administration Fee” only comes into force on 1st January 2025. New direction in section 2.2.Citation, commencement, extent, application and interpretation (3) Directions 2(2)(b) comes...

Source: DHSC 11.12.24 Existing emergency measures banning the sale and supply of puberty-suppressing hormones will be made indefinite, following official advice from medical experts. Sale and supply of puberty blockers...